Combination of an alpha-adrenergic antagonist and a nitrogen oxide donor for treating female sexual dysfunctions

Use according to either of the preceding claims, in which the nitrogen monoxide donor is a compound chosen from arginine, sodium nitroprusside, organic nitrates or nitrites, thionitrites and molsidomine, as well as, where appropriate, the pharmaceutically acceptable salts of these compounds.

Use according to any one of the preceding claims, in which the α-adrenergic receptor antagonist is yohimbine.

Use according to the preceding claim, in which said medicinal product is prepared in a pharmaceutical form allowing the administration of a dose of from 2 mg to 10 mg, especially from 2 mg to 8 mg and in particular from 4 mg to 6 mg, of yohimbine, in one or two dosage intakes, said dose being calculated as the weight of yohimbine in free base form.

Use according to any one of the preceding claims, in which the nitrogen monoxide donor is arginine.

Use according to the preceding claim, in which said medicinal product is prepared in a pharmaceutical form allowing the administration of a dose of from 1 g to 8 g and in particular from 2 g to 6 of arginine, in one or two dosage intakes, said dose being calculated as the weight of arginine in free base form.

Use according to any one of the preceding claims, in which the α-adrenergic receptor antagonist is yohimbine in free or salified form, and the nitrogen monoxide donor is arginine, in free or salified form.